Key Deals for the Week: Accenture, Berkshire Hills Bancorp, NXP Semiconductors and More
As Quantum Computing Stocks Soar, Wall Street Analysts Take Bullish Stance
Dividend Roundup: Mastercard, Broadcom, Southwest Airlines, Waste Management, and More
SPDR S&P 500 High Dividend ETF Declares Quarterly Distribution of $0.5468
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
Natural Gas Nears 2-Year Highs, Inflation Fears Mount As Utility Costs Climb: 3 Energy Stocks Rise
Kinder Morgan Shares Are Trading Higher After the Company's Tennessee Gas Pipeline Subsidiary Announced Its Decision to Proceed With Its Mississippi Crossing Project.
(GILD) - Analyzing Gilead Sciences's Short Interest
Your Healthcare Costs Are Soaring! US Spending Reached $5 Trillion In 2023 With Major Increase in Obesity and Diabetes Drugs, Hospital Services
Gilead Raises Assembly Bio Stake to ~30%
Quantum Computing Company IonQ Rises After D.A. Davidson Initiates With Buy Rating
Quantum Leap: The Future Bet Behind the Surge in Stocks.
With Alphabet releasing the next-generation Willow quantum computing chip, the field of quantum computing instantly became the focus of the investment market.
Quantum Computing, Rigetti, D-Wave Skyrocket Up To 300% In 5 Sessions After Google Unveils Willow Chip, But Analysts Urge Caution: 'Not Every TikTok Guitarist Is The Next Taylor Swift'
BioArctic Partners With Bristol Myers Squibb In Licensing Deal For PyroGlutamate-Amyloid-Beta Antibody Program
Shares of Oil and Gas Companies Are Trading Lower Amid Overall Market Weakness Following the Fed's Rate Decision to Cut Rates by 25 Basis Points.
Shares of Companies Within the Broader Tech Sector Are Trading Lower Amid Overall Market Weakness Following the Fed's Rate Decision to Cut Rates by 25 Basis Points.
HashiCorp Edges Higher on Report About FTC's Review of IBM Deal
Dow's Drop: How Blue-chips Have Fared During Index's Peak Turned Worst-run in Decades
Insitro Receives $25M In Milestone Payments From Bristol Myers Squibb For Achievement Of Discovery Milestones And Selection Of First Novel Genetic Target For ALS
ONEOK Analyst Ratings